Br Med J 1968;1:335-339 (10 February), doi:10.1136/bmj.1.5588.335
Observations on recent increase in mortality from asthma.
F. E. Speizer,
R. Doll,
P. Heaf
The mortality attributed to asthma has increased annually in
England and Wales from 1960 to 1965. The increase is more pronounced
at ages 5 to 34 years than at older ages and is most pronounced
at ages 10 to 14 years. In this last age group the mortality
increased nearly eight times in seven years, and in 1966 asthma
accounted for 7% of all deaths. No comparable increase has been
observed in any other country, but smaller increases at ages
10 to 19 years have been observed in Australasia, Japan, western
Europe, and the United States. There is no evidence to suggest
that there has been any change in diagnostic habits, certification
of deaths, or methods of classification which could account
for the increase in Great Britain, and it is concluded that
the increase is real. General practitioners' records provide
no evidence of an increase in prevalence and it seems probable
that there has been an increase in case fatality. No environmental
hazards are known which could have increased the severity of
the disease, and the possibility has to be considered that the
increase may be due to new methods of treatment. Corticosteroids
have been used increasingly since 1952, and in Great Britain
the use of pressurized aerosols containing sympathomimetics
has increased rapidly since 1960.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
This article has been cited by other articles:
-
Wijesinghe, M., Weatherall, M., Perrin, K., Crane, J., Beasley, R.
(2009). International Trends in Asthma Mortality Rates in the 5- to 34-Year Age Group: A Call for Closer Surveillance. Chest
135: 1045-1049
[Abstract]
[Full text]
-
Sears, M. R., Ottosson, A., Radner, F., Suissa, S.
(2009). Long-acting {beta}-agonists: a review of formoterol safety data from asthma clinical trials. Eur Respir J
33: 21-32
[Abstract]
[Full text]
-
Chen, A. M, Bollmeier, S. G, Finnegan, P. M
(2008). Long-Acting Bronchodilator Therapy for the Treatment of Chronic Obstructive Pulmonary Disease. The Annals of Pharmacotherapy
42: 1832-1842
[Abstract]
[Full text]
-
Wijesinghe, M, Perrin, K, Harwood, M, Weatherall, M, Beasley, R
(2008). The risk of asthma mortality with inhaled long acting {beta}-agonists. Postgrad. Med. J.
84: 467-472
[Abstract]
[Full text]
-
Town, G I, Crane, J
(2006). Respiratory health and lung research in New Zealand. Chronic Respiratory Disease
3: 167-169
[Abstract]
-
Samet, J. M., Speizer, F. E.
(2006). Sir Richard Doll, 1912-2005. Am J Epidemiol
164: 95-100
[Full text]
-
Lynd, L. D., Guh, D. P., Pare, P. D., Anis, A. H.
(2002). Patterns of Inhaled Asthma Medication Use: A 3-Year Longitudinal Analysis of Prescription Claims Data From British Columbia, Canada. Chest
122: 1973-1981
[Abstract]
[Full text]
-
Bernstein, I. L.
(2002). {beta}2-Agonists: Deja vu All Over Again : The Second-Generation Controversy. Chest
122: 763-765
[Full text]
-
Donahue, J. G., Weiss, S. T., Livingston, J. M., Goetsch, M. A., Greineder, D. K., Platt, R.
(1997). Inhaled Steroids and the Risk of Hospitalization for Asthma. JAMA
277: 887-891
[Abstract]
-
Speizer, F. E., Doll, R.
(1987). Reappraisal of the United Kingdom Epidemic of Fatal Asthma. Arch Intern Med
147: 1853-1853
[Abstract]
-
Esdaile, J. M., Feinstein, A. R., Horwitz, R. I.
(1987). A Reappraisal of the United Kingdom Epidemic of Fatal Asthma: Can General Mortality Data Implicate a Therapeutic Agent?. Arch Intern Med
147: 543-549
[Abstract]
-
Strunk, R. C., Mrazek, D. A., Fuhrmann, G. S. W., LaBrecque, J. F.
(1985). Physiologic and Psychological Characteristics Associated With Deaths due to Asthma in Childhood: A Case-Controlled Study. JAMA
254: 1193-1198
[Abstract]
-
Tobin, M. J.
(1985). Use of Bronchodilator Aerosols. Arch Intern Med
145: 1659-1663
[Abstract]
-
Winter, B.
(1981). Bilateral Carotid Body Resection in Children with Severe Bronchial Asthma: A Retrospective Study. VASC ENDOVASCULAR SURG
15: 399-408
-
Kinney, E. L., Trautlein, J. J., Harbaugh, C. V., Lambert, D., Zelis, R. F.
(1978). Ventricular Tachycardia After Terbutaline. JAMA
240: 2247-2247
[Abstract]
-
SHIM, C., WILLIAMS, M. H. Jr.
(1975). Cardiac Response to Repeated Doses of Isoproterenol Aerosol. ANN INTERN MED
83: 208-211
[Abstract]
-
Harris, W. S.
(1973). Toxic Effects of Aerosol Propellants on the Heart. Arch Intern Med
131: 162-166
[Abstract]
-
Sheehy, A. F., DiBenedetto, R., Lefrak, S., Lyons, H. A.
(1972). Treatment of Status Asthmaticus: A Report of 70 Episodes. Arch Intern Med
130: 37-42
[Abstract]
-
Taylor, G. J. IV, Harris, W. S.
(1970). Cardiac Toxicity of Aerosol Propellants. JAMA
214: 81-85
[Abstract]
-
(1968). Symposium on Steroids and Childhood Asthma: Steroid Therapy in Childhood Asthma?. CLIN PEDIATR
7: 439-443
[Abstract]